glp-1 news november 3 2025 Medications and Gallbladder Health: What You Should Know How Employers Can Manage GLP-1

doi: 10.1038/nm1196-1254 [DOI] [PubMed] [Google Scholar] 42.Ayala JE, Bracy DP, James FD, et al

No membership fees, no surprise charges, and HSA/FSA eligibility further reduce true out-of-pocket burden

[DOI] [PMC free article] [PubMed] [Google Scholar] [50].Dogan SE, Kukonmaz SM, Koc G, Aypar E, ulha C

This context of high prevalence, progressive natural history, and multisystemic impact underscores the urgent need for effective, broadly applicable pharmacotherapies

Clinical and experimental studies demonstrate that GLP-1RAs decrease hepatic fat content and fibrosis markers, reduce circulating pro-inflammatory cytokines, and promote favorable adipokine profiles, collectively dampening immune activation [9,25]